Erratum: Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1 (Proceedings of the National Academy of Sciences of the United States of America (2015) 112 (1773–1778) DOI: 10.1073/pnas.1424642112);Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 6, 2015, Pages 1773-1778

  Rao, Feng ^a   Xu, Jing ^a   Fu, Chenglai ^a   Cha, Jiyoung Y ^a   Gadalla, Moataz M ^a   Xu, Risheng ^a   Barrow, James C ^a   Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cell adhesion; Cell matrix adhesion; IP6K; LKB1; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; INOSITOL DERIVATIVE; INOSITOL HEXAKISPHOSPHATE KINASE 2; INOSITOL PENTAKISPHOSPHATE; INOSITOL PHOSPHATE; INOSITOL PYROPHOSPHATE; LIVER KINASE B1; PHOSPHOTRANSFERASE; PYROPHOSPHORIC ACID DERIVATIVE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 1-DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; INOSITOL HEXAKISPHOSPHATE KINASE; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, MOUSE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL CULTURE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TUMOR GROWTH; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; METABOLISM; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; HUMANS; IMMUNOPRECIPITATION; INOSITOL PHOSPHATES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR); PROTEIN-SERINE-THREONINE KINASES;

EID: 84922671892     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2019638117     Document Type: Erratum

References (43)

1. Chakraborty A, et al. (2010) Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 143(6):897-910.
2. Illies C, et al. (2007) Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 318(5854):1299-1302.
3. Szijgyarto Z, Garedew A, Azevedo C, Saiardi A (2011) Influence of inositol pyrophosphates on cellular energy dynamics. Science 334(6057):802-805.
4. Jadav RS, Chanduri MV, Sengupta S, Bhandari R (2013) Inositol pyrophosphate synthesis by inositol hexakisphosphate kinase 1 is required for homologous recombination repair. J Biol Chem 288(5):3312-3321.
5. Rao F, et al. (2014) Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2. Mol Cell 54(1):119-132.
6. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH (1999) Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol 9(22):1323-1326.
7. Chakraborty A, Kim S, Snyder SH (2011) Inositol pyrophosphates as mammalian cell signals. Sci Signal 4(188):re1.
8. Mulugu S, et al. (2007) A conserved family of enzymes that phosphorylate inositol hexakisphosphate. Science 316(5821):106-109.
9. Saiardi A, Nagata E, Luo HR, Snowman AM, Snyder SH (2001) Identification and characterization of a novel inositol hexakisphosphate kinase. J Biol Chem 276(42): 39179-39185.
10. Maag D, et al. (2011) Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc Natl Acad Sci USA 108(4):1391-1396.
11. Xu R, et al. (2013) Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death. Sci Signal 6(269):ra22.
12. Kim S, et al. (2011) Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metab 13(2):215-221.
13. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890.
14. Cavallaro U, Dejana E (2011) Adhesion molecule signalling: Not always a sticky business. Nat Rev Mol Cell Biol 12(3):189-197.
15. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6(1):56-68.
16. Carretero J, et al. (2010) Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17(6):547-559.
17. Eneling K, et al. (2012) Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability. FASEB J 26(8):3230-3239.
18. Wang G, et al. (2008) Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Lung Cancer 62(2):162-172.
19. Roy BC, et al. (2010) Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 70(2):136-145.
20. Alessi DR, Sakamoto K, Bayascas JR (2006) LKB1-dependent signaling pathways. Annu Rev Biochem 75:137-163.
21. Lizcano JM, et al. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23(4):833-843.
22. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H (2009) LKB1 and AMPK family signaling: The intimate link between cell polarity and energy metabolism. Physiol Rev 89(3):777-798.
23. Baas AF, et al. (2003) Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22(12):3062-3072.
24. Song P, et al. (2008) Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem 283(18): 12446-12455.
25. Koldobskiy MA, et al. (2010) p53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc Natl Acad Sci USA 107(49):20947-20951.
26. Rajput A, et al. (2008) Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res 147(2):276-281.
27. Luo HR, et al. (2001) GRAB: A physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase. Neuron 31(3):439-451.
28. Brehm MA, Wundenberg T, Williams J, Mayr GW, Shears SB (2013) A non-catalytic role for inositol 1,3,4,5,6-pentakisphosphate 2-kinase in the synthesis of ribosomal RNA. J Cell Sci 126(Pt 2):437-444.
29. Wang H, DeRose EF, London RE, Shears SB (2014) IP6K structure and the molecular determinants of catalytic specificity in an inositol phosphate kinase family. Nat Commun 5:4178.
30. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247(4940):322-324.
31. Zhang QC, et al. (2012) Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature 490(7421):556-560.
32. Bang S, Chen Y, Ahima RS, Kim SF (2014) Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. Mol Endocrinol 28(7):1186-1193.
33. Kline ER, Shupe J, Gilbert-Ross M, Zhou W, Marcus AI (2013) LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence. J Biol Chem 288(24):17663-17674.
34. Goodwin JM, et al. (2014) An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. Mol Cell 55(3): 436-450.
35. Okon IS, Coughlan KA, Zou MH (2014) Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells. J Biol Chem 289(3):1639-1648.
36. Koivunen JP, et al. (2008) Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 99(2):245-252.
37. Morrison BH, Bauer JA, Kalvakolanu DV, Lindner DJ (2001) Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. J Biol Chem 276(27):24965-24970.
38. Aoki M, Sobek V, Maslyar DJ, Hecht A, Vogt PK (2002) Oncogenic transformation by beta-catenin: Deletion analysis and characterization of selected target genes. Oncogene 21(46):6983-6991.
39. Roca H, et al. (2013) Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS ONE 8(10):e76773.
40. Nilsson J, et al. (2010) Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res 70(5):2020-2029.
41. Barcellos-Hoff MH, Cucinotta FA (2014) New tricks for an old fox: Impact of TGFβ on the DNA damage response and genomic stability. Sci Signal 7(341):re5.
42. Ewan KB, et al. (2002) Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Res 62(20):5627-5631.
43. Wang H, et al. (2013) Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS ONE 8(2): e56664.